<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>104(7)</volume><submitter>Mazzola M</submitter><pubmed_abstract>The nucleophosmin 1 gene (&lt;i>NPM1&lt;/i>) is the most frequently mutated gene in acute myeloid leukemia. Notably, &lt;i>NPM1&lt;/i> mutations are always accompanied by additional mutations such as those in cohesin genes &lt;i>RAD21&lt;/i>, &lt;i>SMC1A&lt;/i>, &lt;i>SMC3&lt;/i>, and &lt;i>STAG2&lt;/i> but not in the cohesin regulator, nipped B-like (&lt;i>NIPBL&lt;/i>). In this work, we analyzed a cohort of adult patients with acute myeloid leukemia and &lt;i>NPM1&lt;/i> mutation and observed a specific reduction in the expression of &lt;i>NIPBL&lt;/i> but not in other cohesin genes. In our zebrafish model, overexpression of the mutated form of &lt;i>NPM1&lt;/i> also induced downregulation of &lt;i>nipblb&lt;/i>, the zebrafish ortholog of human &lt;i>NIPBL&lt;/i> To investigate the hematopoietic phenotype and the interaction between mutated &lt;i>NPM1&lt;/i> and &lt;i>nipblb&lt;/i>, we generated a zebrafish model with &lt;i>nipblb&lt;/i> downregulation which showed an increased number of myeloid progenitors. This phenotype was due to hyper-activation of the canonical Wnt pathway: myeloid cells blocked in an undifferentiated state could be rescued when the Wnt pathway was inhibited by &lt;i>dkk1b&lt;/i> mRNA injection or indomethacin administration. Our results reveal, for the first time, a role for &lt;i>NIPBL&lt;/i> during zebrafish hematopoiesis and suggest that an interplay between &lt;i>NIPBL/NPM1&lt;/i> may regulate myeloid differentiation in zebrafish and humans through the canonical Wnt pathway and that dysregulation of these interactions may drive leukemic transformation.</pubmed_abstract><journal>Haematologica</journal><pagination>1332-1341</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6601076</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&lt;i>NIPBL&lt;/i>: a new player in myeloid cell differentiation.</pubmed_title><pmcid>PMC6601076</pmcid><pubmed_authors>Mazzola M</pubmed_authors><pubmed_authors>Fumagalli M</pubmed_authors><pubmed_authors>Marasca F</pubmed_authors><pubmed_authors>Saitta C</pubmed_authors><pubmed_authors>Bresciani E</pubmed_authors><pubmed_authors>Ferrari L</pubmed_authors><pubmed_authors>Fazio G</pubmed_authors><pubmed_authors>Cotelli F</pubmed_authors><pubmed_authors>Biondi A</pubmed_authors><pubmed_authors>Bodega B</pubmed_authors><pubmed_authors>Parma M</pubmed_authors><pubmed_authors>Pistocchi A</pubmed_authors><pubmed_authors>Pezzotta A</pubmed_authors><pubmed_authors>Cazzaniga G</pubmed_authors><pubmed_authors>Deflorian G</pubmed_authors><pubmed_authors>Riva P</pubmed_authors><pubmed_authors>Marozzi A</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>NIPBL&lt;/i>: a new player in myeloid cell differentiation.</name><description>The nucleophosmin 1 gene (&lt;i>NPM1&lt;/i>) is the most frequently mutated gene in acute myeloid leukemia. Notably, &lt;i>NPM1&lt;/i> mutations are always accompanied by additional mutations such as those in cohesin genes &lt;i>RAD21&lt;/i>, &lt;i>SMC1A&lt;/i>, &lt;i>SMC3&lt;/i>, and &lt;i>STAG2&lt;/i> but not in the cohesin regulator, nipped B-like (&lt;i>NIPBL&lt;/i>). In this work, we analyzed a cohort of adult patients with acute myeloid leukemia and &lt;i>NPM1&lt;/i> mutation and observed a specific reduction in the expression of &lt;i>NIPBL&lt;/i> but not in other cohesin genes. In our zebrafish model, overexpression of the mutated form of &lt;i>NPM1&lt;/i> also induced downregulation of &lt;i>nipblb&lt;/i>, the zebrafish ortholog of human &lt;i>NIPBL&lt;/i> To investigate the hematopoietic phenotype and the interaction between mutated &lt;i>NPM1&lt;/i> and &lt;i>nipblb&lt;/i>, we generated a zebrafish model with &lt;i>nipblb&lt;/i> downregulation which showed an increased number of myeloid progenitors. This phenotype was due to hyper-activation of the canonical Wnt pathway: myeloid cells blocked in an undifferentiated state could be rescued when the Wnt pathway was inhibited by &lt;i>dkk1b&lt;/i> mRNA injection or indomethacin administration. Our results reveal, for the first time, a role for &lt;i>NIPBL&lt;/i> during zebrafish hematopoiesis and suggest that an interplay between &lt;i>NIPBL/NPM1&lt;/i> may regulate myeloid differentiation in zebrafish and humans through the canonical Wnt pathway and that dysregulation of these interactions may drive leukemic transformation.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2024-02-15T18:42:50.762Z</modification><creation>2019-07-30T07:02:36Z</creation></dates><accession>S-EPMC6601076</accession><cross_references><pubmed>30630974</pubmed><doi>10.3324/haematol.2018.200899</doi></cross_references></HashMap>